Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial

BACKGROUND: Albumin treatment of ischemic stroke was associated with cardiopulmonary adverse events in previous studies and a low incidence of intracranial hemorrhage. We sought to describe the neurological and cardiopulmonary adverse events in the ALIAS Part 2 Multicenter Trial. METHODS: Ischemic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Michael D., Martin, Renee H., Palesch, Yuko Y., Moy, Claudia S., Tamariz, Diego, Ryckborst, Karla J., Jones, Elizabeth B., Weisman, David, Pettigrew, Creed, Ginsberg, Myron D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556660/
https://www.ncbi.nlm.nih.gov/pubmed/26325387
http://dx.doi.org/10.1371/journal.pone.0131390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556660/
https://www.ncbi.nlm.nih.gov/pubmed/26325387
http://dx.doi.org/10.1371/journal.pone.0131390

Ejemplares similares